COVID-19: the aftermath and the asthmatics
OA Version
Citation
Abstract
The emergence of the COVID-19 pandemic has raised concerns about the potential impact on individuals with comorbid conditions, such as asthma. This study aims to investigate the consequences of long COVID in asthmatic patients, focusing on the persistence of asthma symptoms and the worsening of lung function. SARS-CoV-2 is a highly contagious virus that primarily spreads through respiratory droplets and aerosols. Despite the innovative vaccines and development of some therapeutic options, the treatment of this virus is largely based around symptom management.
Asthma is a common, chronic obstructive lung disease characterized by respiratory symptoms such as coughing, wheezing, and shortness of breath. Asthmatic individuals may have compromised lung function, making them more susceptible to the adverse effects of SARS-CoV-2 infection. However, the direct impact of long COVID on asthmatics is still poorly understood.
The goal of this study is to address the persistence of asthma symptoms in individuals with asthma who have recovered from SARS-CoV-2 and are experiencing long COVID. Pulmonary function tests will be obtained from asthmatic patients who have recovered from the COVID-19 virus to measure the FEV1, FVC and the FEV1/FVC ratio to assess lung function. This data will be analyzed to explore the relative risk of these previously COVID-19 infected asthmatic patients in developing worsening disease.
Understanding the impact of long COVID on asthmatic patients is essential for enhancing medical management and treatment strategies for this population. The findings from this study can potentially contribute to the development of tailored interventions and improved care, as well as quality of life, for asthmatic individuals who have been infected with COVID-19.